专利号:US-10920229-B2 优先权日:2014-07-16 标 题:Method for improving heterologous synthesis of Escherichia coli into polyketides and use of same 发明人:WANG YONG; XIONG ZHIQIANG; SONG SHUJIE; LIU QIAOXIA; WANG JIANFENG 权利人:SHANGHAI INST BIOLOGICAL SCIENCES CAS; CAS CENTER FOR EXCELLENCE IN MOLECULAR PLANT SCIENCES 摘要:The present invention relates to a method for improving the heterologous synthesis of a polyketide by E. coli and use thereof. The yield of the polyketide heterologously synthesized by E. coli is significantly increased by attenuating the expression of seventy-two genes, such as sucC and talB, in a host strain, wherein the highest yield increase rate can reach 60% or more. Currently, erythromycin is the most clear model compound in the study on the biosynthesis of polyketids. The production strain of the present invention enables massive accumulation of 6-deoxyerythronolide (6-dEB), an erythromycin precursor, in the fermentation process, laying the foundation for the industrial production of the heterologous synthesis of erythromycin by E. coli.
专利号:US-2024197774-A1 优先权日:2021-04-16 标 题:Synthesis of Antimicrobial PVP-coated Bismuth Nanoparticles 发明人:LOPEZ-RIBOT JOSE; VAZQUEZ-MUNOZ ROBERTO 权利人:UNIV TEXAS 摘要:Described herein is a facile, fast, and economical method for the synthesis of BAL-mediated PVP-BiNPs, using basic laboratory instruments and reagents readily available in most laboratories.
专利号:US-2007015260-A1 优先权日:2002-03-14 标 题:Synthesis of synthons for the manufacture of bioactive compounds 发明人:WONG CHI-HUEY; LIU JUNJIE; DESANTIS GRACE; BURK MARK 权利人:SCRIPPS RESEARCH INST 摘要:The present invention is based on the discovery that 2-deoxyribose-5-phosphate aldolase (DERA, EC 4.1.2.4) and variants thereof can be used to catalyze sequential asymmetric aldol reactions between a wide variety of donor and acceptor aldehydes. The reaction products typically contain at least two new stereogenic centers and can be produced in enantiomerically pure form. As such, DERA catalyzed asymmetric aldol chemistry can be exploited to produce synthons for the synthesis of a variety of bioactive molecules.
专利号:US-8557979-B2 优先权日:2004-06-10 标题 :Carbapenem antibacterials with gram-negative activity and processes for their preparation 发明人:CHOI WOO-BAEG; KOWALIK EWA 权利人:CHOI WOO-BAEG; KOWALIK EWA; FOB SYNTHESIS INC 摘要:The present invention provides β-methyl carbapenem compounds and pharmaceutical compositions useful in the treatment of bacterial infections and methods for treating such infections using such compounds and/or compositions. The invention includes administering an effective amount of a carbapenem compound or salt and/or prodrug thereof to a host in need of such a treatment. The present invention is also in the field of synthetic organic chemistry and is specifically provides an improved method of synthesis of β-methyl carbapenems which are useful as antibacterial agents.
专利号:US-2013316397-A1 优先权日:2012-04-30 标 题:Cell-Free Polypeptide Synthesis 发明人:AIREN ISOKEN; SWARTZ JAMES ROBERT 权利人:UNIV LELAND STANFORD JUNIOR 摘要:Methods, microbial strains and reaction mixtures for cell-free synthesis of polypeptides are provided. The methods of the invention utilize a reaction mixture comprising microbial cell extracts that are modified in the protein component relative to an extract from a native cell. The modification may be one or both of (i) increased levels of proteins that increase synthetic yield; and (ii) decreased levels of proteins that decrease synthetic yield. The modification may result from a genetic modification of the microbial cell, or from ex vivo supplementation or depletion of an extract.
专利号:US-10933051-B2 优先权日:2017-06-09 标 题 :Carbapenem compounds and compositions for the treatment of bacterial infections 发明人:CHOI WOO-BAEG; TOMIOKA TAKASHI; JOO HYUNG-YEUL; TRUONG PHONG; MIN BRIAN 权利人:FOB SYNTHESIS INC 摘要:The present invention provides carbapenem compounds and pharmaceutical compositions useful in the treatment of bacterial infections, including drug resistant or multiple-drug resistant bacterial infections, and methods for treating such infections using such compounds and/or compositions. The invention includes administering an effective amount of a carbapenem compound or salt and/or prodrug thereof to a host in need of such a treatment.
1: Sivakumar B, Parthasarathy K, Murugan R, Jeyasudha R, Murugan S, Saranghdar RJ. Isolation and characterisation of degradation impurities in the cefazolin sodium drug substance. Sci Pharm. 2013 Jun 4;81(4):933-50. doi: 10.3797/scipharm.1304-14. eCollection 2013 Dec. 2: Wei D, Zhou R, cheng S, Feng W, Li B, Wang Y, Jia D, Zhou Y, Guo H. Microarc oxidized TiO2 based ceramic coatings combined with cefazolin sodium/chitosan composited drug film on porous titanium for biomedical applications. Mater Sci Eng C Mater Biol Appl. 2013 Oct;33(7):4118-25. doi: 10.1016/j.msec.2013.05.053. Epub 2013 Jun 6. doi: 10.1002/bio.2398. Epub 2012 Jul 15. 6: Yoruk O, Ucuncu H, Sutbeyaz Y, Aktan B, Gur FO. The effects of methylprednisolone and cefazolin sodium on antioxidant status in experimentally induced maxillary sinusitis. Acta Otolaryngol. 2009 Oct;129(10):1101-5. doi: 10.1080/00016480802552584. Chinese. Chinese. Epub 2005 Jul 7.
合成参考文献
参考文献:10.1007/s10195-011-0145-z 摘要:Kurklu M, Yildiz C, Kose O, Yurttas Y, Karacalioglu O, Serdar M, Deveci S. Effect of alpha-tocopherol on bone formation during distraction osteogenesis: a rabbit model. Journal of Orthopaedics and Traumatology. 2011 Jul 15;12(3):153–8. doi: 10.1007/s10195-011-0145-z.